Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bruce Berkowitz, Low Returns, High Redemptions and ‘Average Down’

Bruce Berkowitz has had an amazing track record. For years, his Fairholme Fund has produced consistently high returns. Of course, with the sweet comes the sour – no one gets it right every time and Berkowitz is no exception.

Bruce Berkowitz’s Fairholme Fund in 2011

After investors in Bruce Berkowitz’s Fairholme Fund lost almost 25% of their investments, they withdrew almost $6 billion from the fund since the start of the year, dropping the Fairholme Fund portfolio from $20 billion to just over $13 billion. Why the influx? Investors who sell can claim their losses, offsetting tax burdens. There is also the issue that Berkowitz has roughly 75% of his fund invested in financial stocks, leaving some investors to opt to invest in an exchange-traded fund and save the high fees associated with hedge funds. Also, Berkowitz has been losing key staff. He lost two co-managers in 2008 and, more recently, Charles Fernandez.

FAIRHOLME (FAIRX) Bruce Berkowitz

Bruce Berkowitz’s Investment Strategy

Bruce Berkowitz has been emphasizing that having a large volume of cash in the fund is essential to his strategy. Now that so many redemptions have come in, the amount of cash in the Fairholme Fund has shrunk considerably. The Wall Street Journal reports, “The fund has gone from 25% cash in February to low single digits.” The Wall Street Journal notes that he has “often taken big positions in stocks only to see them fall sharply in price.” The same column ask questioned Berkowitz’s strategy of “using massive inflows of new investor money to ‘average down’ the acquisition cost of stocks which fell after he took a stake.” It explained that any “advantage would disappear should the inflow of cash dry up. And, if investors started pulling money out of the fund, it could be forced to sell some shares at a loss.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!